Title,URL,Publication Day,Publication Month,Publication Year,Journal Name,Journal Volume,Journal Issue,Journal ISSN,Author 1 First Name,Author 1 Last Name,Author 2 First Name,Author 2 Last Name,Author 1 Affiliation,Author 3 First Name,Author 3 Last Name,Author 4 First Name,Author 4 Last Name,Author 5 First Name,Author 5 Last Name,Author 6 First Name,Author 6 Last Name,Author 7 First Name,Author 7 Last Name,Author 8 First Name,Author 8 Last Name,Author 9 First Name,Author 9 Last Name,Author 10 First Name,Author 10 Last Name,Author 11 First Name,Author 11 Last Name,Author 12 First Name,Author 12 Last Name,Author 13 First Name,Author 13 Last Name,Author 14 First Name,Author 14 Last Name,Author 15 First Name,Author 15 Last Name,Author 16 First Name,Author 16 Last Name,Author 17 First Name,Author 17 Last Name,Author 18 First Name,Author 18 Last Name,Author 19 First Name,Author 19 Last Name,Author 20 First Name,Author 20 Last Name,Author 21 First Name,Author 21 Last Name,Author 22 First Name,Author 22 Last Name,Author 23 First Name,Author 23 Last Name,Author 24 First Name,Author 24 Last Name,Author 25 First Name,Author 25 Last Name,Author 26 First Name,Author 26 Last Name,Author 27 First Name,Author 27 Last Name,Collective Author 1,Author 2 Affiliation,Author 3 Affiliation,Author 4 Affiliation,Author 5 Affiliation,Author 6 Affiliation,Author 7 Affiliation,Author 8 Affiliation,Author 9 Affiliation,Author 10 Affiliation,Author 11 Affiliation,Author 12 Affiliation,Author 13 Affiliation,Author 14 Affiliation,Author 15 Affiliation,Author 16 Affiliation,Author 17 Affiliation,Author 18 Affiliation,Author 19 Affiliation,Author 20 Affiliation,Author 21 Affiliation,Author 22 Affiliation,Author 23 Affiliation,Collective Author 2,Author 28 First Name,Author 28 Last Name,Author 29 First Name,Author 29 Last Name,Author 30 First Name,Author 30 Last Name,Author 31 First Name,Author 31 Last Name,Author 32 First Name,Author 32 Last Name,Author 33 First Name,Author 33 Last Name
current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast,https://pubmed.ncbi.nlm.nih.gov/28402908/,31,03,2017,Cancer treatment reviews,55,,1532-1967,Carlos,Martínez-Pérez,Arran K,Turnbull,"Breast Cancer Now Edinburgh Research Team, Western General Hospital, University of Edinburgh, United Kingdom. Electronic address: carlos.martinez-perez@igmm.ed.ac.uk.",Gregory E,Ekatah,Laura M,Arthur,Andrew H,Sims,Jeremy S,Thomas,J Michael,Dixon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Breast Cancer Now Edinburgh Research Team, Western General Hospital, University of Edinburgh, United Kingdom.","Edinburgh Breast Unit, Western General Hospital, University of Edinburgh, United Kingdom.","Breast Cancer Now Edinburgh Research Team, Western General Hospital, University of Edinburgh, United Kingdom.","Breast Cancer Now Edinburgh Research Team, Western General Hospital, University of Edinburgh, United Kingdom.","Department of Pathology, Western General Hospital, Edinburgh, United Kingdom.","Edinburgh Breast Unit, Western General Hospital, University of Edinburgh, United Kingdom.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
optimization of radiotherapy fractionation schedules based on radiobiological functions,https://pubmed.ncbi.nlm.nih.gov/28830219/,22,08,2017,The British journal of radiology,90,1079,1748-880X,Fernando,Pizarro,Araceli,Hernández,"1 Department of Medical Physics, University Hospital of Burgos, Burgos, Spain.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2 Department of Medical Physics, Clinical Hospital of Zaragoza, Zaragoza, Spain.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma,https://pubmed.ncbi.nlm.nih.gov/29275078/,21,12,2017,Brachytherapy,17,2,1873-1449,John M,Stahl,Shari,Damast,"Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.",Trevor J,Bledsoe,Yi,An,Vivek,Verma,James B,Yu,Melissa R,Young,Nataniel H,Lester-Coll,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.","Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.","Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.","Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE.","Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.","Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.","Department of Radiation Oncology, University of Vermont Medical Center, Burlington, VT. Electronic address: Nataniel.lester-coll@uvm.edu.",,,,,,,,,,,,,,,,,,,,,,,,,,,,
refining patient selection for reirradiation of head and neck squamous carcinoma in the imrt era: a multi-institution cohort study by the miri collaborative,https://pubmed.ncbi.nlm.nih.gov/28865925/,17,06,2017,"International journal of radiation oncology, biology, physics",100,3,1879-355X,Matthew C,Ward,Nadeem,Riaz,"Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: mward@sero.net.",Jimmy J,Caudell,Neal E,Dunlap,Derek,Isrow,Sara J,Zakem,Joshua,Dault,Musaddiq J,Awan,John A,Vargo,Dwight E,Heron,Kristin A,Higgins,Jonathan J,Beitler,Samuel,Marcrom,Drexell H,Boggs,Comron,Hassanzadeh,Chandana A,Reddy,James A,Bonner,Min,Yao,Mitchell,Machtay,Farzan,Siddiqui,Andy M,Trotti,Nancy Y,Lee,Shlomo A,Koyfman,,,,,,,,,Multi-Institution Reirradiation (MIRI) Collaborative,"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.","Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.","Department of Radiation Oncology, University of Louisville, Louisville, Kentucky.","Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan.","Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.","Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.","Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.","Department of Radiation Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.","Department of Radiation Oncology, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.","Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.","Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.","Department of Radiation Oncology, University of Alabama, Birmingham, Alabama.","Department of Radiation Oncology, University of Alabama, Birmingham, Alabama.","School of Medicine, University of Missouri, Kansas City, Missouri.","Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.","Department of Radiation Oncology, University of Alabama, Birmingham, Alabama.","Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.","Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.","Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan.","Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.","Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.","Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.",,,,,,,,,,,,,
increasing fractional doses increases the probability of benign psa bounce in patients undergoing definitive hdr brachytherapy for prostate cancer,https://pubmed.ncbi.nlm.nih.gov/28586946/,16,01,2017,"International journal of radiation oncology, biology, physics",98,1,1879-355X,Carlin R,Hauck,Hong,Ye,"Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.",Peter Y,Chen,Gary S,Gustafson,Amy,Limbacher,Daniel J,Krauss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.","Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.","Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.","Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.","Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan. Electronic address: Daniel.krauss@beaumont.edu.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
normal tissue complication probability (ntcp) modelling of severe acute mucositis using a novel oral mucosal surface organ at risk,https://pubmed.ncbi.nlm.nih.gov/28057404/,03,01,2017,Clinical oncology (Royal College of Radiologists (Great Britain)),29,4,1433-2981,J A,Dean,L C,Welsh,"Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: jamie.dean@icr.ac.uk.",K H,Wong,A,Aleksic,E,Dunne,M R,Islam,A,Patel,P,Patel,I,Petkar,I,Phillips,J,Sham,U,Schick,K L,Newbold,S A,Bhide,K J,Harrington,C M,Nutting,S L,Gulliford,,,,,,,,,,,,,,,,,,,,,,"Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.","Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.","Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.",,,,,,,,,,,,,,,,,,,
treatment-associated toxicities reported by patients with early-stage invasive breast cancer,https://pubmed.ncbi.nlm.nih.gov/28117882/,24,01,2017,Cancer,123,11,1097-0142,Christopher R,Friese,Jordan M,Harrison,"Department of Systems, Populations, and Leadership, School of Nursing, and Institute for Healthcare Policy and Innovation, University of Michigan.",Nancy K,Janz,Reshma,Jagsi,Monica,Morrow,Yun,Li,Ann S,Hamilton,Kevin C,Ward,Allison W,Kurian,Steven J,Katz,Timothy P,Hofer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Systems, Populations, and Leadership, School of Nursing, and Institute for Healthcare Policy and Innovation, University of Michigan.","Department of Health Behavior and Health Education, School of Public Health, University of Michigan.","Department of Radiation Oncology, University of Michigan School of Medicine.",Memorial Sloan-Kettering Cancer Center.,"Department of Biostatistics, University of Michigan School of Public Health.",University of Southern California Keck School of Medicine.,"Rollins School of Public Health, Emory University.","Departments of Medicine and Health Research and Policy, Stanford University Medical Center.","Departments of Internal Medicine and Health Management and Policy, Schools of Medicine and Public Health, University of Michigan.","Veterans Affairs Center for Clinical Management Research, Health Services Research and Development Service Center of Innovation and Department of Internal Medicine, University of Michigan.",,,,,,,,,,,,,,,,,,,,,,,,,
a bayesian network and heuristic approach for systematic characterization of radiotherapy receipt after breast-conservation surgery,https://pubmed.ncbi.nlm.nih.gov/28659177/,28,06,2017,BMC medical informatics and decision making,17,1,1472-6947,Milton,Soto-Ferrari,Diana,Prieto,"Health Systems Decision Support Laboratory (HSDS), Industrial and Entrepreneurial Engineering & Engineering Management Department, Western Michigan University, 4601 Campus Drive, Kalamazoo, 49008, MI, USA.",Gitonga,Munene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Health Systems Decision Support Laboratory (HSDS), Industrial and Entrepreneurial Engineering & Engineering Management Department, Western Michigan University, 4601 Campus Drive, Kalamazoo, 49008, MI, USA. diana.prieto@wmich.edu.","Western Michigan University School of Medicine, 1000 Oakland Drive, Kalamazoo, 49008, MI, USA.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma,https://pubmed.ncbi.nlm.nih.gov/28666368/,29,11,2017,Neuro-oncology,19,12,1523-5866,Yushen,Qian,Satoshi,Maruyama,"Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.",Haju,Kim,Erqi L,Pollom,Kiran A,Kumar,Alexander L,Chin,Jeremy P,Harris,Daniel T,Chang,Allison,Pitt,Eran,Bendavid,Douglas K,Owens,Ben Y,Durkee,Scott G,Soltys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.","Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; Department of Health Research and Policy, Stanford University, Stanford, California; Division of Management Science and Engineering, Department of Engineering, Stanford University, Stanford, California; VA Palo Alto Health Care System, and Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University, Stanford, California; Swedish American Hospital, a division of the University of Wisconsin, Rockford, Illinois.",,,,,,,,,,,,,,,,,,,,,,,
longitudinal regret after treatment for low- and intermediate-risk prostate cancer,https://pubmed.ncbi.nlm.nih.gov/28678408/,05,07,2017,Cancer,123,21,1097-0142,Lauren M,Hurwitz,Jennifer,Cullen,"Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.",Daniel J,Kim,Sally,Elsamanoudi,Jane,Hudak,Maryellen,Colston,Judith,Travis,Huai-Ching,Kuo,Kevin R,Rice,Christopher R,Porter,Inger L,Rosner,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Department of Urology, Walter Reed National Military Medical Center, Bethesda, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.","Center for Prostate Disease Research, Department of Defense, Rockville, Maryland.",,,,,,,,,,,,,,,,,,,,,,,,,
providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy,https://pubmed.ncbi.nlm.nih.gov/28836985/,24,08,2017,BMC medical informatics and decision making,17,1,1472-6947,James,Abe,Jennifer M,Lobo,"Department of Radiation Oncology, University of Virginia School of Medicine, 1240 Lee Street, Box 800383, Charlottesville, VA, 22908, USA.",Daniel M,Trifiletti,Timothy N,Showalter,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.","Department of Radiation Oncology, University of Virginia School of Medicine, 1240 Lee Street, Box 800383, Charlottesville, VA, 22908, USA.","Department of Radiation Oncology, University of Virginia School of Medicine, 1240 Lee Street, Box 800383, Charlottesville, VA, 22908, USA. tns3b@virginia.edu.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
patterns of care for elderly patients with locally advanced head and neck cancer,https://pubmed.ncbi.nlm.nih.gov/28366573/,29,01,2017,"International journal of radiation oncology, biology, physics",98,4,1879-355X,Jesus E,Juarez,Jehee,Choi,"Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.",Maie,St John,Elliot,Abemayor,Mindi,TenNapel,Allen M,Chen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Radiation Oncology, University of Kansas School of Medicine, Kansas City, Kansas.","Department of Otolaryngology-Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.","Department of Otolaryngology-Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.","Department of Radiation Oncology, University of Kansas School of Medicine, Kansas City, Kansas.","Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Radiation Oncology, University of Kansas School of Medicine, Kansas City, Kansas. Electronic address: achen5@kumc.edu.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
when and how to treat an imrt patient on a second accelerator without replanning?,https://pubmed.ncbi.nlm.nih.gov/29287919/,26,12,2017,Medical dosimetry : official journal of the American Association of Medical Dosimetrists,43,4,1873-4022,Teh,Lin,Murshed,Hossain,"Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address: Teh.Lin@fccc.edu.",Jiajin,Fan,C-M Charlie,Ma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.","Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.","Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery,https://pubmed.ncbi.nlm.nih.gov/29079937/,28,10,2017,Breast cancer research and treatment,167,3,1573-7217,Rinaa S,Punglia,Wei,Jiang,"Department of Radiation Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02115, USA. rpunglia@lroc.harvard.edu.",Stuart R,Lipsitz,Melissa E,Hughes,Stuart J,Schnitt,Michael J,Hassett,Larissa,Nekhlyudov,Ninah,Achacoso,Stephen,Edge,Sara H,Javid,Joyce C,Niland,Richard L,Theriault,Yu-Ning,Wong,Laurel A,Habel,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA.","Department of Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA.","Division of Population Sciences, Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA.","Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.","Division of Population Sciences, Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA.","Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.","Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.","Department of Surgery, Roswell Park Cancer Institute, University at Buffalo, Buffalo, NY, USA.","Department of Surgery, University of Washington Medical Center, University of Washington School of Medicine, Seattle, WA, USA.","Department of Diabetes and Cancer Discovery Science, City of Hope, Comprehensive Cancer Center, Duarte, CA, USA.","Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.","Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.","Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.",,,,,,,,,,,,,,,,,,,,,,
health economics of targeted intraoperative radiotherapy (targit-iort) for early breast cancer: a cost-effectiveness analysis in the united kingdom,https://pubmed.ncbi.nlm.nih.gov/28819067/,17,08,2017,BMJ open,7,8,2044-6055,Anil,Vaidya,Param,Vaidya,"School of Public Health, University of Alberta, Edmonton, Canada.",Brigitte,Both,Chris,Brew-Graves,Max,Bulsara,Jayant S,Vaidya,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"O-ZONE 2.0 Inc. HEOR Consultancy, Edmonton, Canada.","Carl-Zeiss Meditec AG, Oberkochen, Germany.","Division of Surgery and Interventional Science, University College London, London, UK.","Institute for Health Research, University of Notre Dame, Fremantle, Australia.","Division of Surgery and Interventional Science, University College London, London, UK.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
treatment decisions and employment of breast cancer patients: results of a population-based survey,https://pubmed.ncbi.nlm.nih.gov/28990155/,09,10,2017,Cancer,123,24,1097-0142,Reshma,Jagsi,Paul H,Abrahamse,"Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.",Kamaria L,Lee,Lauren P,Wallner,Nancy K,Janz,Ann S,Hamilton,Kevin C,Ward,Monica,Morrow,Allison W,Kurian,Christopher R,Friese,Sarah T,Hawley,Steven J,Katz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.","Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.","Departments of Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, Michigan.","Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan.","Keck School of Medicine, Department of Preventive Medicine, University of Southern California, Los Angeles, California.","Department of Epidemiology, Emory University, Atlanta, Georgia.","Memorial Sloan-Kettering Cancer Center, New York, New York.","Departments of Medicine and Health Research and Policy, Stanford University, Stanford, California.","Department of Systems, Populations and Leadership, University of Michigan, Ann Arbor, Michigan.","Departments of Internal Medicine and Health Management and Policy, University of Michigan and Ann Arbor VA Health Care System, Center for Clinical Management Research, Ann Arbor, MI.","Department of Internal Medicine and Health Management and Policy, University of Michigan, Ann Arbor, Michigan.",,,,,,,,,,,,,,,,,,,,,,,,
figo stage ib1 cervical carcinoma: place and principles of brachytherapy,https://pubmed.ncbi.nlm.nih.gov/28233697/,21,02,2017,Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique,21,2,1769-6658,A,Huertas,S,Oldrini,"Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France. Electronic address: huertas@hotmail.fr.",J-P,Nesseler,F,Courrech,P,Rétif,C,Charra-Brunaud,D,Peiffert,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France.","Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France.","Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France.","Department of Radiotherapy, Mercy Hospital, centre hospitalier régional de Metz-Thionville, 1, allée du Château, 57530 Ars-Laquenexy, France.","Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France.","Department of Radiotherapy, Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54500 Vandœuvre-lès-Nancy, France.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
a radiobiological markov simulation tool for aiding decision making in proton therapy referral,https://pubmed.ncbi.nlm.nih.gov/29254594/,23,11,2017,Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB),44,,1724-191X,Annabelle M,Austin,Michael J J,Douglass,"Department of Physics, University of Adelaide, Adelaide, SA 5005, Australia. Electronic address: annabelle.austin@adelaide.edu.au.",Giang T,Nguyen,Scott N,Penfold,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Physics, University of Adelaide, Adelaide, SA 5005, Australia; Department of Medical Physics, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Electronic address: michael.douglass@adelaide.edu.au.","School of Mathematical Sciences, University of Adelaide, Adelaide, SA 5005, Australia. Electronic address: giang.nguyen@adelaide.edu.au.","Department of Physics, University of Adelaide, Adelaide, SA 5005, Australia; Department of Medical Physics, Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Electronic address: Scott.Penfold@sa.gov.au.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"cost-effectiveness analysis comparing conventional, hypofractionated, and intraoperative radiotherapy for early-stage breast cancer",https://pubmed.ncbi.nlm.nih.gov/29059428/,01,11,2017,Journal of the National Cancer Institute,109,11,1460-2105,Ashish A,Deshmukh,Shervin M,Shirvani,"Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.",Lincy,Lal,J Michael,Swint,Scott B,Cantor,Benjamin D,Smith,Anna,Likhacheva,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.","Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.","Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.","Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.","Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.","Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL; Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ; The University of Texas Health Science Center at Houston School of Public Health, Houston, TX; The University of Texas Health Science Center at Houston Medical School, Center for Clinical Research and Evidence-Based Medicine, Houston, TX; Department of Health Services Research and Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
